Behavioral Health Group (BHG) Company Profile

Background

Behavioral Health Group (BHG) is a leading provider of outpatient opioid addiction treatment services in the United States. Established in 2006 and headquartered in Dallas, Texas, BHG operates a network of treatment centers dedicated to delivering comprehensive, personalized, evidence-based medical and behavioral therapies for individuals with opioid use disorder. The company's mission is to restore lives, strengthen families, and rejuvenate communities by providing accessible and effective treatment options.

Key Strategic Focus

BHG's strategic focus centers on offering a "whole-patient" approach to the treatment of substance use disorders. This includes:

• Medication-Assisted Treatment (MAT): Utilizing FDA-approved medications such as buprenorphine, methadone, and naltrexone to support recovery.

• Behavioral Health Counseling: Providing individual and group counseling, crisis intervention, case management, and education on coping skills.

• Health Screening Services: Conducting assessments for conditions beyond opioid use disorder, including mental health conditions and chronic comorbidities.

By integrating these services, BHG aims to meet each patient's unique needs and facilitate long-term recovery.

Financials and Funding

BHG has experienced significant growth since its inception. In 2011, the company was acquired by Frontenac, a private equity firm, and later sold to The Vistria Group in 2018. In 2023, Comvest Partners acquired BHG, further supporting its expansion and operational initiatives.

Pipeline Development

BHG continually expands its network to increase access to treatment services. Recent developments include:

• Acquisitions: In 2020, BHG acquired Huntsville Recovery and Stevenson Recovery in Alabama, enhancing its service offerings in the region.

• Expansion into New Markets: In 2021, BHG expanded into Rhode Island by acquiring the Center for Treatment & Recovery in Pawtucket, marking its presence in the state.

These strategic moves aim to address the growing need for opioid addiction treatment services across the country.

Technological Platform and Innovation

BHG leverages technology to enhance patient care and operational efficiency. Notable initiatives include:

• Telehealth Services: Offering virtual counseling sessions to increase accessibility for patients.

• Data Analytics: Utilizing data-driven approaches to monitor patient progress and outcomes, ensuring personalized and effective treatment plans.

Leadership Team

BHG's leadership team comprises experienced professionals dedicated to advancing the company's mission:

• Jay Higham: Chief Executive Officer

• James Hopwood: Chief Financial Officer

• Julie Koenig: Chief Operating Officer

• Paul Di Vincenzo: Chief Technology Officer

• Jaimee McGuire, JD: Chief Compliance Officer and Vice President of Compliance & Privacy Officer

Leadership Changes

In July 2022, BHG appointed Russell Goin as Chief People Officer, bringing extensive experience in human resources to support the company's growth and employee engagement strategies.

Competitor Profile

Market Insights and Dynamics

The U.S. behavioral health market was valued at approximately $92.2 billion in 2024 and is projected to reach $151.62 billion by 2034, growing at a CAGR of 5.1%. This growth is driven by increasing awareness and demand for mental health and substance use disorder treatments.

Competitor Analysis

Key competitors in the behavioral health sector include:

• Acadia Healthcare: A publicly traded company offering behavioral health services across the U.S. and the U.K.

• American Addiction Centers (AAC): A for-profit addiction treatment provider offering residential and outpatient services.

• Lifestance Health: A provider of outpatient behavioral health services, including therapy and psychiatry, operating across multiple states.

Strategic Collaborations and Partnerships

BHG has engaged in strategic partnerships to enhance its service offerings:

• Sonara Health Partnership: In December 2023, BHG partnered with Sonara Health to implement a remote dosing application, improving access to methadone treatment for patients in South Carolina.

Operational Insights

BHG's strategic considerations include:

• Market Positioning: As the largest network of Joint Commission-accredited outpatient opioid treatment centers in the U.S., BHG holds a significant position in the market.

• Competitive Advantages: BHG's comprehensive, patient-centric approach and commitment to evidence-based treatments distinguish it from competitors.

Strategic Opportunities and Future Directions

BHG's future strategies focus on:

• Expansion: Continuing to grow its network through acquisitions and new facility openings to meet increasing demand.

• Technological Integration: Enhancing telehealth capabilities and data analytics to improve patient outcomes and operational efficiency.

• Community Engagement: Strengthening relationships with local communities to raise awareness and reduce the stigma associated with opioid use disorder.

Contact Information

For more information, visit BHG's official website: bhgrecovery.com

Note: Specific contact details such as addresses, phone numbers, and email addresses have been omitted in accordance with provided instructions.